By Arnab Paul
(Reuters) - Indian shares fell on Monday, in line with broader Asian markets, as global growth worries, including the U.S.-Sino tariff war, and lacklustre domestic earnings muted sentiment.
While the U.S. President Donald Trump declared he had no plans to meet his Chinese counterpart Xi Jinping before the March 1 deadline to achieve a trade deal, sentiment was further dented by fears of another government shutdown after talks on border security funding collapsed between Democratic and Republican lawmakers.
Meanwhile, Asian shares started the week on the backfoot as investors were unable to shake off worries about global growth, U.S. politics and the Sino-U.S. trade dispute, keeping the safe-haven dollar bid near a six-week top against major currencies.
"The auto sector is creating serious problems for the markets, we have seen some dismal numbers and forecast and it could create a cascading effect," said Krish Subramanyam, co-head, equity advisory, at Altamount Capital.
"Even though the markets, in general, are rising, the advance decline ratio is pretty much in the negative so I see Nifty between 10,700-11,000 with a negative bias in the immediate short term."
The broader NSE Nifty was down 0.48 percent at 10,890.10, as of 0604 GMT, while the benchmark BSE Sensex slipped 0.32 percent to 36,426.85.
Dr. Reddy's Laboratories Ltd was the biggest loser on the NSE index after falling as much as 5.6 percent. The generic drugmaker's Hyderabad-based plant was issued a Form 483 with 11 observations by the U.S. Food And Drug Administration after market hours on Friday.
The FDA Form 483 notifies the company's management of objectionable conditions.
(Reporting By Arnab Paul in Bengaluru, Editing by Sherry Jacob-Phillips)
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)